In homogeneous catalysis, the catalyst is in the same phase as the reactant. The number of collisions between reactants and catalyst is at a maximum.In a patent, 26238-14-2, name is 5-(Trifluoromethyl)isobenzofuran-1,3-dione, introducing its new discovery. name: 5-(Trifluoromethyl)isobenzofuran-1,3-dione
The present invention relates to the novel isoindolone derivatives of the formula I 1in which R1 to R6 have the meanings stated in the claims. The inventive compounds are suitable as antiarrhythmic medicaments with a cardioprotective component for infarction prophylaxis and infarction treatment and for the treatment of angina pectoris. They also inhibit in a preventive manner the pathophysiological processes associated with the development of ischemia-induced damage, in particular in the triggering of ischemia-induced cardiac arrhythmias and of heart failure.
We’ll also look at important developments in the pharmaceutical industry because understanding organic chemistry is important in understanding health, medicine, the role of 26238-14-2, and how the biochemistry of the body works.name: 5-(Trifluoromethyl)isobenzofuran-1,3-dione
Reference：
Benzofuran – Wikipedia,
Benzofuran | C8H3660O – PubChem